ID
12210
Description
Post Marketing Surveillance (PMS) Study of Ryzodeg™ (Insulin Degludec /Insulin Aspart) in Patients With Diabetes Mellitus in Routine Clinical Practice in India; ODM derived from: https://clinicaltrials.gov/show/NCT02230618
Link
https://clinicaltrials.gov/show/NCT02230618
Keywords
Versions (2)
- 10/18/15 10/18/15 -
- 10/19/15 10/19/15 - Julian Varghese
Uploaded on
October 18, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0 Legacy
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Diabetes NCT02230618
Eligibility Diabetes NCT02230618
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
allergy; ryzodeg
Data type
boolean
Alias
- UMLS CUI [1]
- C0020517
- UMLS CUI [2]
- C3661220
Description
participation
Data type
boolean
Alias
- UMLS CUI [1]
- C0679823
Description
Clinical Research; Disruption
Data type
boolean
Alias
- UMLS CUI [1]
- C0008972
- UMLS CUI [2]
- C0332453
Description
therapy; ryzodeg
Data type
boolean
Alias
- UMLS CUI [1]
- C0087111
- UMLS CUI [2]
- C3661220
Description
clinical trials other
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0008976
- UMLS CUI [1,2]
- C0205394
Description
pregnant; breast feeding
Data type
boolean
Alias
- UMLS CUI [1]
- C0549206
- UMLS CUI [2]
- C0006147
Similar models
Eligibility Diabetes NCT02230618
- StudyEvent: Eligibility
C3661220 (UMLS CUI [2])
C3661220 (UMLS CUI [2])
C0332453 (UMLS CUI [2])
C3661220 (UMLS CUI [2])
C0205394 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2])